On the fly News and insights, exclusive to thefly.com

2019-12-06 10:04:32 IR Ingersoll-Rand $132.14 / +3.19 (+2.47%) , EPZM Epizyme $16.57 / +1.25 (+8.16%) … 10:04 12/06/19 12/06 10:04 12/06/19 10:04	Fly Intel: Top five analyst upgrades Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ingersoll-Rand (IR) upgraded to Outperform from Market Perform at Wells Fargo with analyst Deepa Raghavan saying she believes the standalone ClimateCo potential is ready to be realized post-split. 2. Epizyme (EPZM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Lebowitz saying he expects data this weekend at the American Society of Hematology meeting to bolster confidence in tazemetostat for follicular lymphoma. 3. Philips (PHG) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Michael Jungling saying he thinks its organic sales growth momentum will continue and he believes its Q3 margin outlook downgrade has reset expectation. 4. Montage Resources (MR) upgraded to Outperform from Sector Perform at Scotiabank. 5. HCA Healthcare (HCA) upgraded to Buy from Neutral at BofA/Merrill with analyst Kevin Fischbeck saying the recent trend of elevated utilization with few catalysts in the coming 6 months should benefit hospitals but hurt managed care organizations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. IR Ingersoll-Rand $132.14 / +3.19 (+2.47%) EPZM Epizyme $16.57 / +1.25 (+8.16%) PHG Philips $47.08 / +0.58 (+1.25%) MR Montage Resources $5.66 / +0.36 (+6.79%) HCA HCA Healthcare $143.72 / +3.09 (+2.20%)	07 Dec 18 Dec 23 Jan

2019-12-06 10:04:32

Ingersoll-Rand

$132.14 / +3.19 (+2.47%)

, EPZM

Epizyme

$16.57 / +1.25 (+8.16%)

… 10:04

12/06/19

12/06

10:04

12/06/19

10:04

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ingersoll-Rand (IR) upgraded to Outperform from Market Perform at Wells Fargo with analyst Deepa Raghavan saying she believes the standalone ClimateCo potential is ready to be realized post-split. 2. Epizyme (EPZM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Lebowitz saying he expects data this weekend at the American Society of Hematology meeting to bolster confidence in tazemetostat for follicular lymphoma. 3. Philips (PHG) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Michael Jungling saying he thinks its organic sales growth momentum will continue and he believes its Q3 margin outlook downgrade has reset expectation. 4. Montage Resources (MR) upgraded to Outperform from Sector Perform at Scotiabank. 5. HCA Healthcare (HCA) upgraded to Buy from Neutral at BofA/Merrill with analyst Kevin Fischbeck saying the recent trend of elevated utilization with few catalysts in the coming 6 months should benefit hospitals but hurt managed care organizations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Ingersoll-Rand